3-hydroxybutyric acid has been researched along with 8-epi-prostaglandin f2alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ceballo, J; Cornejo, P; Escobar, O; Escudero, N; Fernández, V; Fischer, A; Morales, P; Vargas, R; Videla, LA | 1 |
| Li, D; Liu, Y; Sun, R; Xia, M; Zhang, Y | 1 |
1 trial(s) available for 3-hydroxybutyric acid and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients.
Topics: 3-Hydroxybutyric Acid; Aged; Anthocyanins; Antioxidants; Apolipoprotein B-48; Apolipoprotein C-III; Blood Glucose; Body Mass Index; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Dietary Supplements; Dinoprost; Dose-Response Relationship, Drug; Double-Blind Method; Dyslipidemias; Female; Humans; Insulin; Insulin Resistance; Linoleic Acids; Male; Middle Aged; Nutrition Assessment; Oxidative Stress; Triglycerides | 2015 |
1 other study(ies) available for 3-hydroxybutyric acid and 8-epi-prostaglandin f2alpha
| Article | Year |
|---|---|
T₃-induced liver AMP-activated protein kinase signaling: redox dependency and upregulation of downstream targets.
Topics: 3-Hydroxybutyric Acid; AMP-Activated Protein Kinases; Animals; Antioxidants; Dinoprost; Enzyme Activation; Fatty Acids; Gene Expression Regulation, Enzymologic; Injections, Intraperitoneal; Liver; Male; Oxidation-Reduction; Phosphorylation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Signal Transduction; Time Factors; Triiodothyronine | 2014 |